Akari Therapeutics
AKTX
Akari Therapeutics (AKTX) earnings history
Most recent quarter
- Fiscal period
- Q2 2025
- Period end
- Jun 30, 2025
- EPS actual
- −$3.20
- EPS estimate
- −$3.60
- EPS surprise
- +11.11%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2025 | Aug 13, 2025 | −$3.60 | −$3.20 | +11.11% | $0.00 | SEC |
| Q1 2025 | May 14, 2025 | $0.00 | −$5.40 | +0.00% | $0.00 | SEC |
| Q4 2024 | Apr 15, 2025 | −$40.00 | −$6.80 | +83.00% | $0.00 | SEC |
| Q2 2022 | Sep 27, 2022 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q1 2022 | Jul 20, 2022 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q3 2021 | Dec 3, 2021 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q2 2021 | Sep 22, 2021 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q1 2021 | Jun 29, 2021 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q4 2020 | Apr 21, 2021 | $0.00 | −$8.00 | +0.00% | $0.00 | — |
| Q3 2020 | Dec 11, 2020 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q2 2020 | Sep 1, 2020 | $0.00 | $0.00 | +0.00% | $0.00 | — |
| Q1 2020 | May 29, 2020 | $0.00 | $0.00 | +0.00% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did Akari Therapeutics (AKTX) last report earnings?
Akari Therapeutics last reported on Aug 13, 2025, covering fiscal Q2 2025.
Did AKTX beat earnings estimates?
Yes. Akari Therapeutics reported EPS of −$3.20 for Q2 2025 against a −$3.60 estimate — a 11.11% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.